What is Borregaard ASA ADR?
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally.
BRGAY · Verdict
Moderate reward · moderate risk
BRGAY scores well on cash flow and balance sheet with no major weaknesses flagged in the model.
Based on 88% data coverage
BRGAY · Verdict
7% free-cash-flow margin
Interest covered 7.7×
Above average
Model-based scoring. For information only — not financial advice.
Borregaard ASA engages in the development, production, and marketing of specialized biochemicals and biomaterials in Norway, rest of Europe, Asia, the United States, and internationally. It operates in three segments: BioSolutions, BioMaterials, and Fine Chemicals. The company is listed on the OTCGREY in USA, operating in the Basic Materials sector, with a market capitalisation of 1.76B, and a P/E ratio of 24.2x.
The scoring profile indicates limited reward potential at this time, with profitability and valuation offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.